Search results for: “Search”
-
Supreme Court Strikes Down Gene Patents in Breast Cancer Gene Case
By Pete Shanks and Marcy Darnovsky Originally published on Biopolitical Times The Supreme Court’s June 13, 2013 unanimous ruling against Myriad Genetics is a triumph for common sense and the common good, and for scientific research and legal fundamentals as well. The decision means that all of the existing patents on human genes – some […]
-
Reactions to the Supreme Court Ruling on Patenting Human Genes
by Pete Shanks Originally published on Biopolitical Times The unanimous Supreme Court decision [pdf] (June 13, 2013) that human genes may not be patented was greeted with unbridled enthusiasm by the large coalition of plaintiffs and supporters. Early reactions concurred that the decision is indeed a momentous one. The Center for Genetics and Society response […]
-
Mapping the Growth Of Synthetic Biology: Wilson Center Findings For 2013
View the map Download the PDF summary of findings Except from the Wilson Center TRACKING THE GROWTH OF SYNTHETIC BIOLOGY: FINDINGS FOR 2013: Major Findings: The number of entities conducting research in synthetic biology increased significantly between 2009 and 2013, resulting in a total of 508 unique entities in the 2013 inventory [See footnotes1 2 […]
-
About: June 6 Event with Milton Reynolds & Stuart Newman – The Rise of Genetically Modified Humans
On June 6, join Milton Reynolds of Facing History and Ourselves in conversation with Stuart Newman as they consider some of the social justice and ethical challenges associated with these developments. In 1997, New York Medical College cell biologist Stuart Newman applied for a patent on what he called a “humanzee” — part human, part […]
-
DEFEAT AB 926
The Alliance for Human Biotechnology (AHB) is organizing a letter-writing campaign to the California State Senate to oppose Assembly Bill 926 which authorizes paying young women to undergo egg harvesting to extract their eggs for bio-research. The procedure, which includes taking powerful hormones for weeks, has short term risks (including death) and long term risks […]
-
Principles for the Oversight of Synthetic Biology
Download the complete pdf The undersigned, a broad coalition of civil society groups, social movements, local and indigenous communities, public interest, environmental, scientific, human rights, religious and labor organizations concerned about various aspects of synthetic biology’s human health, environmental , social , economic, ethical and other impacts, offer the following declaration, “The Principles for the […]
-
Synthetic Biology 101 Fact Sheets from Friends of the Earth
Download PDF: Synthetic Biology Fact Sheets In May 2010 J. Craig Venter’s company Synthetic Genomics announced that it had made the world’s first organism with a completely synthetic genome. According to Venter, this organism was the first self-replicating species on the planet whose entire biological makeup was created by a computer.1 While the field of […]
-
Mass Release of Synthetically Engineered Plant Seeds via Kickstarter Campaign Draws Protest
An Israeli company seeks to use a loophole in US regulations on genetically engineered plants to conduct a mass release of a genetically modified organism (a glow in the dark Arabidopsis plant) with no regulatory review. Current US regulations, which would apply if the plant were modified using non-synthetic techniques, don’t cover the new gene […]
-
Articles on Human Genetics and Synthetic Biology by Stuart Newman
In advance of his conversation with Milton Reynolds at East Bay Conversations on June 6, 2013, Stuart Newman shares selected articles he has written over the past 10 years on human genetics and synthetic biology. Stuart Newman received an A.B. from Columbia University and a Ph.D. in chemical physics from the University of Chicago. He […]
-
Ethical variability: Drug development and globalizing clinical trials by Adriana Petryna, New School University
Published in American Ethnologist Volume 32 Number 2 May 2005 Globalizing_Clinical_Trials (download pdf) The rapid growth of pharmaceutical markets has led to increased demands for human subjects for drug research, particularly in low-income countries. For regulatory, economic, and even biological reasons, new populations are being pursued as human subjects for pharmaceutical trials. In this article […]